Spectrum of FDG PET/CT findings of uterine tumors

American Journal of Roentgenology

Volumn 195, Issue 3, 2010, Pages 737-743

  Kitajima, Kazuhiro ^a,b   Murakami, Koji ^b   Kaji, Yasushi ^b   Sugimura, Kazuro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

FDG PET CT; MRI; Oncologic imaging; Uterine tumors; Uterus

Indexed keywords

FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADENOMYOSIS; ARTICLE; BENIGN UTERUS TUMOR; CARCINOSARCOMA; CELL DENSITY; COMPUTER ASSISTED TOMOGRAPHY; ENDOMETRIUM; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM SARCOMA; HUMAN; LEIOMYOMA; LEIOMYOSARCOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERUS TUMOR; DIAGNOSTIC USE; ENDOMETRIUM TUMOR; FEMALE; PRECANCER; PROCEDURES; RADIOGRAPHY; SARCOMA; SCINTISCANNING; UTERUS CANCER;

ENDOMETRIAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LEIOMYOMA; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; PRECANCEROUS CONDITIONS; RADIOPHARMACEUTICALS; SARCOMA; TOMOGRAPHY, X-RAY COMPUTED; UTERINE NEOPLASMS;

EID: 77956835640     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.09.4074     Document Type: Article

References (14)

1. 18F-FDG endometrial and ovarian uptake in preand postmenopausal patients: assessment by PET/CT. J Nucl Med 2004; 45:266-271
2. Chura JC, Truskinovsky AM, Judson PL, Johnson L, Geller MA, Downs LS. Positron emission tomography and leiomyomas: clinical analysis of 3 cases of PET scan-positive leiomyomas and literature review. Gynecol Oncol 2007; 104:247-252 (Pubitemid 46075146)
3. Nishizawa S, Inubushi M, Kido A, et al. Incidence and characteristics of uterine leiomyomas with FDG uptake. Ann Nucl Med 2008; 22:803-810
4. Kitajima K, Murakami K, Yamasaki E, Kaji Y, Sugimura K. Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI. Ann Nucl Med 2008; 22:505-512
5. 18F-fluorodeoxyglucose PET - initial experience. Radiology 2008; 248:599-605
6. 18F-fluorodeoxyglucose uptake. Cancer 2009; 115:3548-3554
7. Kidd EA, Siegel BA, Dehdashti F, Grigsby PW. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer 2007; 110:1738-1744
8. Singh AK, Grigsby W, Dehdasht F, Herzog T, Siegel BA. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma. Int J Radiat Oncol Biol Phys 2003; 56:489-493 (Pubitemid 36542908)
9. Hope AJ, Saha P, Grigsby PW. FDG-PET in carcinoma of the uterine cervix with endometrial extension. Cancer 2006; 106:196-200
10. Yen TC, See LC, Lai CH, et al. Standardized uptake in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer. Eur J Nucl Med Mol Imaging 2008; 35:493-501
11. Sironi S, Buda A, Picchio M, et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology 2006; 238:272-279
12. Kitajima K, Murakami K, Yamasaki E, et al. Accuracy of FDG PET/CT in detecting pelvic and paraortic lymph node metastasis in patients with endometrial cancer. AJR 2008; 190:1652-1658 (Pubitemid 351798544)
13. 18F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging. Gynecol Oncol 2001; 80:372-377
14. 18F-fluorodeoxyglucose positron emission tomography in uterine carcinosarcoma. Eur J Nucl Med Mol Imaging 2008; 35:484-492